Bolt Biotherapeutics (BOLT)

Currency in USD
5.600
-0.020(-0.36%)
Closed·
After Hours
5.6000.000(0.00%)
·
BOLT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected today
BOLT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.6005.740
52 wk Range
5.20014.800
Key Statistics
Prev. Close
5.6
Open
5.6
Day's Range
5.6-5.74
52 wk Range
5.2-14.8
Volume
1.81K
Average Volume (3m)
27.66K
1-Year Change
-60.56%
Book Value / Share
24.42
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BOLT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
40.000
Upside
+614.29%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period

Bolt Biotherapeutics News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Bolt Biotherapeutics Company Profile

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company dBDC-3042, develops dan agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer; and BDC-4182, an next-generation boltbody technology platform that targets claudin 18.2, which is overexpressed in gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc.; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Compare BOLT to Peers and Sector

Metrics to compare
BOLT
Peers
Sector
Relationship
P/E Ratio
−0.2x−3.7x−0.5x
PEG Ratio
−0.43−0.170.00
Price/Book
0.2x1.9x2.6x
Price / LTM Sales
3.0x9.9x3.3x
Upside (Analyst Target)
255.9%63.5%42.8%
Fair Value Upside
Unlock21.2%6.5%Unlock

Analyst Ratings

1 Buy
3 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 40.000
(+614.29% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.29 / -0.41
Revenue / Forecast
1.20M / 400.00K
EPS Revisions
Last 90 days

BOLT Income Statement

People Also Watch

110.29
CRDO
-3.84%
0.434
ADIL
+4.57%
135.54
ALAB
-1.73%
2.180
VOR
+3.32%
4.8700
CLRB
-3.75%

FAQ

What Stock Exchange Does Bolt Trade On?

Bolt is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Bolt?

The stock symbol for Bolt is "BOLT."

What Is the Bolt Market Cap?

As of today, Bolt market cap is 10.74M.

What Is Bolt's Earnings Per Share (TTM)?

The Bolt EPS (TTM) is -33.12.

When Is the Next Bolt Earnings Date?

Bolt will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is BOLT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bolt Stock Split?

Bolt has split 1 times.

How Many Employees Does Bolt Have?

Bolt has 52 employees.

What is the current trading status of Bolt (BOLT)?

As of 06 Aug 2025, Bolt (BOLT) is trading at a price of 5.60, with a previous close of 5.60. The stock has fluctuated within a day range of 5.60 to 5.74, while its 52-week range spans from 5.20 to 14.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.